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ABSTRACT 
Objective: The aim of study was to develop a rapid assay, dye labelled monoclonal antibody assay (DLMAA), using 
non-radioactive organic synthetic dyes for identification of Toxic Shock Syndrome Toxin-1 (TSST-1) producing strains of 
Staphylococcus aureus. 
Materials and Methods: The assay protocol required only two simple steps; addition of TSST-1 antigen to a nitrocellulose 
membrane and then adding a colloidal dye labelled antibody (D/A) suspension detection reagent. 
Results: The sensitivity and specificity of the assay was determined relative to positive and negative strains compared to an 
ELISA assay. Overall 100% agreement was found between both assays. The sensitivity for detection of TSST-1 was 30 ng.
Conclusion: The DLMAA did not require handling and disposal of radioactive materials. It is a rapid qualitative technique 
for detection of TSST-1 toxin at room temperature within a short time.
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INTRODUCTION
Toxic Shock Syndrome Toxin -1 (TSST-1) is an 
extracellular  superantigen  toxin  produced  by  some 
strains of Staphylococcus aureus. TSST-1 is one of 
the causes of Toxic Shock Syndrome (TSS). Toxic 
Shock Syndrome is a rare but serious consequence 
of  burn  wound  infection  and  other  staphylococcal 
infections and also is a disease that affects multiple 
organs and may be fatal (1). It is characterised by 
rapid  fever,  arterial  hypotension,  diffuse cutaneous 
rash,  circulatory  failure,  vomiting,  diarrhoea, 
myalgia, epidermis scaling, hypo-albuminemia and 
organ failure (multiple organ dysfunction syndrome– 
MODS)  (2).  If  the  symptoms  or  infection  are  not 
properly treated soon after the onset of symptoms, a 
fatal shock may develop within 24 h (3). Neill et al. 
found that approximately 20% of all S. aureus isolates 
produced TSST-1 (4). Approximately, 55% of strains 
of Staphylococcus aureus isolated from a paediatric 
burns unit produced at least one superantigen toxin 
including TSST-1and  enterotoxins A-D  (5). At  the 
present,  in  order  to  distinguish  between  TSST-1 
producing and non-TSST-1 producing strains of S. 
aureus, methods such as ELISA (6) and immune-blot 
assay are available (7). The gene for TSST-1 (tst) can 
be detected using PCR but not all strains containing the 
tst gene express TSST-1 (8). It has been reported that 
almost all strains (90%) from patients with menstrual 
TSS  synthesise  TSST-1,  whereas  only  50-60%  of 
isolates from non-menstrual cases of TSS produce 
this protein (9). PCR is also an expensive technique. 
Some of these methods are relatively time consuming. 
They require at least 24 h for interpretable results and 
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some also require special reagents or equipment. The 
ELISA method is more sensitive and specific than the 
other methods, but it is labour intensive and is more 
expensive (10). The development of a rapid assay 
for TSST-1 production would speed up identification 
of toxin producing strains. Gribnau et al. suggested 
that  organic-synthetic,  hydrophobic  colloidal  dye 
particles,  and  non-radioactive  dye  labels  could  be 
easily prepared from a wide range of commercially 
available disperses dyes (11). These could be used to 
label antibodies by simple physical adsorption and 
several detection methods can be applied to the final 
determination of the label such as visual observation 
and  fluorimetry.  The  colloidal  dye  labelling  of 
monoclonal antibodies is an alternative to current types 
of labelled immunoassays (12). Recent developments 
using  various  labels  now  enable  the  detection  of 
specific  TSST-1  antigen  using  the  corresponding 
species-specific monoclonal antibodies (13). 
In  the  present  study,  readily  available  disperse 
dyes were used for dying monoclonal anti-TSST-1 
antibodies and applied for TSST-1 antigen detection 
using  fine  aqueous  suspensions  of  dye-labelled 
antibodies at room temperature within a short time 
(4 hours).
MATERIALS  AND  METHODS
Organisms and culture conditions. The S. aureus 
strains used in this investigation were: T1 (TSST-1 
positive FR 1187S Courtesy of D. Taylor, University 
of  Leeds,  originally  from  Bergdoll),  T2  (TSST-1 
producer,  West  Lancashire  Health  Authority), 
T3  (TSST-1  producer,  West  Lancashire  Health 
Authority),  T4  (TSST-1  producer,  confirmed  case 
of TSS, Bury, UK) and T5 (TSST-1 producer, Bury, 
Health  Authority),  B68  (Enterotoxin  A  producer), 
B19 (Enterotoxin B producer), B27 (Enterotoxin C 
producer) and B78 (non-toxin producer). All strains 
were  supplied  by  Professor  V.  Edwards-Jones, 
Manchester  Metropolitan  University,  Manchester, 
UK. 
One loop of S. aureus was streaked to give single 
colonies on Brain Heart Infusion (BHI) agar (LabM) 
and incubated overnight at 37°C. A few single colonies 
from the culture plate were suspended in saline to give 
turbidity equal to that of a McFarland 0.5 standard. 
One ml of this suspension was inoculated into 100 
ml BHI broth in a 250 ml conical flask and incubated 
overnight at 37°C in a water bath shaker at 150 rpm. 
Ten ml of the culture was centrifuged at 25, 000 × g 
at 4ºC for 20 min. The supernatant fluid was removed 
and stored at -70°C for toxin assay.
Assay  of  enterotoxins  (A-D)  and TSST-1.  The 
supernatant  fluids  were  tested  for  the  presence  of 
enterotoxins  and  TSST-1  using  Reverse  Passive 
Latex Agglutination  (RPLA)  test  kits  from  Oxoid 
Unipath  (TST-RPLA,  TD  940A  for  TSST-1  and 
SET-RPLA, TD900A for enterotoxins) according to 
the manufacturers specifications. Briefly, phosphate 
buffered saline (PBS, 25 µl) containing 5% bovine 
serum albumin was dispensed in each well of two 
rows in a 96 well conical bottom microtitre plate. 
Supernatant fluid (25 µl) was added to the first and 
second well of each row and doubling dilutions were 
performed to give titres ranging from 1:2 to 1:256. 
25  µl  of  latex  suspension  sensitised  with  specific 
antibodies against TSST-1 or enterotoxins was added 
to each well in the first row. Twenty-five microliters 
of  control  latex  suspension  sensitised  with  non-
immune rabbit immunoglobulin was added to each 
well of the second row.  After thorough mixing, the 
plates were incubated in a humidified box for 18-
20 h at room temperature. The titres were expressed 
as the reciprocal of the last dilution which gave an 
agglutination  reaction  (lattice).  The  control  row 
showed a negative reaction (pellet) to indicate there 
was no non-specific reaction.
Specificity of monoclonal antibody. The superna-
tant fluid of TSST-1 toxins (strains T1-T5 from Table 
1)  was  tested  at  dilutions  from  1:20  to  1:640  and 
the optimal working dilution was determined to be 
1:100. Flat-bottomed microtitre plates (Immulon II, 
Dynatech) were coated with a 100 µl of this dilution 
or  100  µl  of  10  µg  ml-1  lyophilised TSST-1  toxin 
obtained from the TST-RPLA kit in 0.1 M carbonate-
bicarbonate  buffer  (Na2CO3  and  NaHCO3  pH  9.6) 
by  incubation  overnight  at  4ºC.  Unbound  toxin 
was removed by washing three times with 0.15 M 
phosphate buffered saline pH 7.2 containing 10 ml 
l-1 Tween 20, (PBS-T). The wells were blocked with 
5% (w/v) powdered milk in PBS-T (150 µl/well) for 
1 h at room temperature. The plates were washed 
3x with PBS-T and incubated with100 µl of a 1 µg 
ml-1 solution of the specific anti-TSST-1 monoclonal 
antibody (Mab; 23.3, 1 mg/ml, was  kindly donated 
by Dr H. Tranter, Centre for Applied Microbiology 
and Research, Porton, Salisbury, Wiltshire, UK, and 
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at RT. The plates were washed 3x with PBS-T and 
100 µl of a 1:2000 dilution of peroxidase conjugate 
added  (Sigma,  A6029)  in  PBS-T  and  incubated 
for  1  h  at  RT.  The  plates  were  again  washed  3x 
with PBS-T, then 100 µl of 100 µg ml-1 3,3’,5,5’-
tetramethylbenzidine free base (Sigma, T5525) in 
phosphate-citrate buffer pH 5.0, containing 0.012% 
v/v hydrogen peroxide was added to each well and 
the plates were incubated at RT for 30 min. The 
absorbance of the solution in each well was read 
at 630 nm using a Dynatech ELISA plate reader. 
The same procedure was performed using alkaline 
phosphatase conjugate (Sigma, A6029) instead of 
peroxidase conjugate.
For  some  experiments  the  possible  interfering 
effects  of  protein A  were  prevented  by  adsorption 
onto normal serum. Culture supernatant of S. aureus 
toxin producing strains, TSST-1, enterotoxin A, B, C 
and  non-toxin  producing  strains  (negative  control) 
were prepared in BHI broth and were pre-treated with 
10% normal rabbit serum to remove protein A. 
 
Dye-labelling: Preparation of dispersed dye.
Six  samples  of  textile  disperse  dyes  (red  BF  200, 
luminous red G, yellow 3GE 200, luminous yellow 
GN,  brilliant  blue  BG-CF  and  dark  blue  3RT-CF) 
were kindly donated by BASF PLC, Cheshire SK8 
6QG,  United  Kingdom.  Dye  particle  suspensions 
were  prepared  using  a  washing  and  centrifugation 
procedure  previously  described  (11).  Briefly,  1  g 
of each dye was suspended in 20 ml distilled water 
and washed 4x by centrifugation at 20,000 × g for 
30 min and resuspension until the supernatant was 
colourless. A final centrifugation was performed at 
125 × g for 30 min in order to remove large particles. 
The suspension was carefully decanted and 0.01% 
(v/v) thiomersol was  added as a preservative. The 
maximum  adsorption  wavelength  (Eλmax)  was 
determined  using  a  Perkin-Elmer  Lambda  5  UV/ 
VIS scanning spectrophotometer using dye particle 
suspensions  solubilised  in  ethanol.  Dye  particle 
suspensions were diluted and standardised in distilled 
water to give λmax = 1. The Mab to TSST-1 toxin was 
linked to the colloidal particle dyes (dye/Mab) using 
a modification of a previously described technique   
(11,14,15). The optimum conditions for dye and Mab 
were  determined  by  using  combinations  of  buffer 
system (10 mM sodium phosphate buffer containing 
2.7 mM NaCl, 33.3 mM sodium phosphate buffer 
containing 0.125 M NaCl) at two different pH (4.5 
and 7.5), four dye concentrations (A = 10, 20, 30 and 
50) and three antibody concentrations (50, 80 and 100 
µg/ml).
 
Preparation  of  dye  antibody  complex. 
Appropriate volumes of dye/Mab were incubated in 
10 mM sodium phosphate buffer (Na2HPO4.12H2O 
and NaH2PO4.2H2O) containing 2.7 mM NaCl, pH 
7.5 for 2 hours to allow for absorption to colloidal dye 
particles at 4°C. The solution was then spiked with 
1/5 volume of a  20%  bovine serum albumin (BSA) 
solution in 5 mM NaCl pH 7.5 and incubated overnight 
at 4°C to stabilise the dye particle surfaces. The dye/
Ab reagent was centrifuged at 17,000 × g and the 
pellet was resuspended in 33.3 mM Na2HPO4.12H2O 
and NaH2PO4.2H2O buffer pH 7.5, containing 0.125 
mM NaCl, 5% BSA and 0.01% thiomersol.
Membrane  strips  and  blocking  reagents. 
Amersham  Hybond-C  and  Amersham  Hybond 
C-Extra  (Amersham  International),  which  contains 
an inert matrix that makes the membrane more robust, 
and blocking reagents (30 g l-1BSA or 5% dried skimed 
powdered milk in PBS) were used to block unbound 
protein.  Subsequent  tests  used  phosphate  buffered 
saline plus milk (PBSM) for blocking with 45 min 
incubation for Amersham Hybond-C (Nitrocellulose, 
Cat. No. RPN 2109).
Dye labelled monoclonal antibody (DLMA) test 
method.  To  standardise the DLMA  assay,  3  µl  of 
different concentrations (50 µg ml-1, 20 µg ml-1, 10 
µg ml-1; equivalent to 150, 60, 30 ng toxin per strip 
respectively) of purified TSST-1 toxin (Sigma,T5662) 
as a positive control and 3 µl of supernatant fluid of 
strains T1-T5 were added as spots of at one end of 
each membrane strip and left to dry for at least 1 h. 
The strips were placed in Petri dishes. The strips were 
washed under tap water for 15 sec and the remaining 
protein  binding  sites  blocked  by  the  addition  of 
PBSM pH 7.4 and incubation for 45 min. The strips 
were washed under tap water for 15 sec and incubated 
with dye/Mab reagent for 2 h at RT. After this time 
the strips were washed once again under tap water for 
15 sec, dried and photographed. 
RESULTS
Specificity  and  sensitivity  of  ELISA.  The 
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determined by testing supernant fluids from TSST-1 
positive, TSST-1 negative strains of S. aureus and 
purified TSST-1 (Sigma, T5662) at concentration of 
50 µg/ml, 20 µg/ml, 10 µg/ml, 5 µg/ml and 2.5 µg/
ml and the results are shown in Fig. 1). There was 
a positive reaction to the purified TSST-1  and the 
culture supernatant fluid from the TSST-1 producing 
strain  but  not  to  those  from  the  enterotoxin A,  B 
or  C  producers  or  the  non-toxin  producing  strain, 
confirming the specificity of the Mab. The sensitivity 
of the ELISA method for identification of TSST-1 
was determined by using different concentrations of 
purified TSST-1 toxin and was 3 µl from a 10 µg/ml 
solution (30 ng/ml) of toxin (Fig. 2).
Detection of the dyes. The optimum wavelength 
for  quantitation  of  each  dye  was  determined  by 
measuring the wavelength for maximum absorption 
(Eλmax)  of  appropriate  dilutions  using  a  scanning 
spectrophotometer (Pye-Unicam SP6 UV / Visible). 
Eλmax for each dye was: yellow 3GE, 441.6; luminous 
yellow, 460.4: luminous red, 548.6; dark blue 3RT, 
587.2; brilliant blue, 667.8 and red BF, 517.4. Dye 
suspensions were then standardized at Eλmax. = 30. 
Optimisation of dye labelled assay. Experiments 
were carried out to determine the optimum concentra-
tion of disperse dyes absorbed to the Mab. Fifty, 80, 
100 and 200 µg of the Mab were added to 1 ml of 
different  dye  suspensions  with  absorbance  (Eλmax 
=  10,  30  and  50).  Nitrocellulose  strips  with  spots 
containing  different  amounts  of  purified  toxin  were 
then incubated with the dye-antibody mixtures washed 
and dried. Adequate colour development was observed 
using 100 µg Mab in 1 ml of dye with E λmax = 30 
and the results are shown in Fig. 3. Clear spots were 
visible with 3 µl of supernatant fluid of the TSST-1 
toxin producing strains or 3 µl of 10 µg ml-1 of the 
purified TSST-1 toxin (30 ng) as capturing antigens. 
This reagent was used in subsequent experiments. 
Preliminary  experiments  showed  that  clearer 
spots were produced with brilliant blue BCG than 
with the other dyes. Red BF, Luminous Yellow and 
Yellow  dyes  adequately  labelled  the  Mab,  but  the 
dots were sometimes difficult to visualise. Positive 
dots were obtained using Dark Blue but there was 
some  background  staining  around  the  dots  on 
the  membrane.  Brilliant  blue  BCG  was  used  for 
subsequent experiments.
Different  concentrations  of  purified  TSST-1 
toxin  (20,  10,  5  and  2.5  µg  ml-1)  were  applied  to 
nitrocellulose strips and the test repeated using the 
optimised  reagent.  The  results  showed  that  clear 
stained spots were visible at concentration of 10 µg/
ml of commercially purified TSST-1 toxin which was 
selected as positive control for further tests.
Specificity of dye labelled assay. The specificity 
of DLMA assay was evaluated using membrane strips 
spotted with 3 µl of supernatant fluid from enterotoxin 
A, B and C producing strains, a non-toxin producing 
strain of S. aureus and purified TSST-1 toxin (Fig. 
4). Supernatant fluids from the enterotoxin producers 
and  the  non-toxin  producer  gave  negative  results. 
Positive spots were obtained with the purified toxin 
and  culture  supernatant  fluids  from  five  different 
TSST-1 producing strains of S. aureus (Fig. 4).
Comparison  of  results  using  ELISA  and  dye 
labelled assay. Nine samples of culture supernatants 
Strain and toxin produced
Detection of TSST-1
ELISA DLMAA
T1 (TSST-1) + +
T2 (TSST-1) + +
T3 (TSST-1) + +
T4 (TSST-1) + +
T5 (TSST-1) + +
B 68 (SEA) - -
B19 (SEB) - -
B27 (SEC) - -
B78 (Non-toxin producer) - -
Purified TSST-1 + +
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Fig. 1. 
Fig. 1. Sensitivity and specificity of the monoclonal antibody 
to TSST-1 in culture supernatant fluids from Staphylococcus 
aureus using ELISA and alkaline phosphatase conjugate.
Supernatants from S. aureus strains: non-toxin producer  , 
SEA  , SEB ▼, SEC s ▼,TSST-1   and purified TSST-1  . 
Fig. 2. 
Fig. 2. The detection of different concentrations of purified 
TSST-1 with monoclonal antibody using ELISA
Supernatant from non-TSST-1 producer  ,  purified TSST-1  . 
Fig. 3. 
Fig.  3.  Sensitivity  and  specificity  of  optimised  dye-
labelled  monoclonal  antibody  to  detect  TSST-1  Top 
row,  detection  of  TSST-1  in  different  dilutions  of 
culture supernatant from a TSST-1 positive S.aureus 
strain;  middle  row  supernatant  fluid  of  enterotoxin 
A-C  producing  strains  compared  to  a  TSST-1  toxin 
producing  strain;  bottom  row  detection  of  different 
quantities of purified TSST-1. 
Fig. 4. 
Fig. 4.  Assay  of  culture  supernatant  fluids  from  five 
different TSST-1 (T1, T2, T3, T4, T5) producing strains 
using the optimised dye labelled monoclonal antibody.
from non-toxin producing and toxin producing strains 
were tested using ELISA and DLMA assays (Table 1). 




The  results  show  that  dye-labelled  antibodies 
can be used to detect TSST-1. The non-radioactive, 
organic-synthetic  dye  label  can  be  easily  prepared 
from  a  wide  range  of  commercially  available 
disperse dyes. The assay procedure developed here 
is economical, with a minimum number of reagents 
and actions per assay. As compared to ELISA, for 
example, dye labelled antibodies have the advantage 
that  the  enzyme  (substrate-chromogen)  incubation 
can be omitted and the results can be read visually 
without  any  special  equipment.  Furthermore,  it  is 
rapid and suited for use in unsophisticated laboratories 
and can be used for epidemiological investigations in 
the field. 
Parsonnet  et  al.  described  a  competitive  ELISA 
capable of quantitating 30 ng of TSST-1 per ml in S. 
aureus culture supernatants (16). This assay was not 
influenced by protein A but did cross-react minimally 
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DLMA assay used here showed no cross reaction with 
enterotoxins. Furthermore, a competitive ELISA with 
enzyme-labelled antigen required purified TSST-1 in 
relatively large amounts for preparation of the enzyme-
antigen conjugate. A more important disadvantage of 
this method is that the competitive ELISA might not 
be readily adapted. This is due to the need to incubate 
enzyme-labelled TSST-1 directly with biologic fluids 
or  tissue  extracts  which  themselves  may  contain 
proteases and may significantly alter the activity of 
the enzyme conjugated to TSST-1. The test described 
here  does  not  require  handling  and  disposal  of 
radioactive materials. It is a rapid qualitative technique 
for detection of TSST-1 at room temperature within a 
short time (4 h). The results showed that clearer spots 
were produced with brilliant blue BCG than with the 
other dyes but all dyes tested gave visible spots.
These  observations  support  previous  work  that 
demonstrated  disperse  dyes  as  suitable  for  DIA 
reagents need to be screened and that selection of a 
particular dye depends on the antibody preparation 
(14). Textile disperse dyes are produced widely in 
the  chemical  industry  and  are  typically  marketed 
in  kilogram  quantities.  Consequently  costs  for  the 
production  of  DLMAA  reagents  are  negligible 
compared with products for Dot-blot or ELISA. The 
sensitivity of DLMA and ELISA were comparable and 
both assays and could detect TSST-1 at concentration 
of 30 ng per 3 µl. ELISA is an accepted method for 
detecting  TSST-1  producing  S.  aureus  (6,10)  but 
cross reaction with Protein A can interfere with the 
ELISA by binding to the coating or enzyme conjugate 
(17). The influence by protein A can be eliminated by 
pre-treatment of samples with 10% rabbit serum. No 
components in the BHI medium used here showed 
interference  with  the  assay.  Research  by  Kvo  and 
Silverman on detection of staphylococcal enterotoxin 
in food showed that sensitivity can be obtained using 
either  phosphatase  or  peroxidase  labelled  antigen 
for  SEA  or  SEB  but  reported  the  possibility  that 
endogenous peroxidase could be present in the culture 
media (18). In the present study the use of alkaline 
phosphatase conjugate eliminated the possibility that 
endogenous peroxidase could be present in the culture 
media. Furthermore, the use of alkaline phosphatase 
conjugate instead of peroxidase conjugate gave more 
consistent results in the assay.
The  DMLAA  method  described  here  could  be 
applied  for  detection  of  TSST-1  produced  from 
strains  isolated  from  patients  with  TSS  either  in 
clinical practice or in fields where simple technology 
is  required.  The  method  presented  here  could 
potentially be applied for qualitative toxin detection 
tests  for  a  variety  of  S.  aureus  enterotoxins  using 
monoclonal  antibodies  to  each  toxin  labelled  with 
different coloured dyes.
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